Clinical trials recruiting in Chelsea, United Kingdom
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 2Phase 2 2Phase 3 5
Conditions recruiting in Chelsea, United Kingdom
Recruiting trials in Chelsea, United Kingdom
- A Phase 1/1b Study of IAM1363 in HER2 Cancers
- A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
- A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Common questions
How many clinical trials are recruiting in Chelsea, United Kingdom?
8 recruiting trials have at least one study site in Chelsea, United Kingdom.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.